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Abstract
The establishment of latency is an essential step for the life-long persistent infection and pathogenesis of Kaposi’s sarcoma-
associated herpesvirus (KSHV). While the KSHV genome is chromatin-free in the virions, the viral DNA in latently infected
cells has a chromatin structure with activating and repressive histone modifications that promote latent gene expression
but suppress lytic gene expression. Here, we report a comprehensive epigenetic study of the recruitment of chromatin
regulatory factors onto the KSHV genome during the pre-latency phase of KSHV infection. This demonstrates that the KSHV
genome undergoes a biphasic chromatinization following de novo infection. Initially, a transcriptionally active chromatin
(euchromatin), characterized by high levels of the H3K4me3 and acetylated H3K27 (H3K27ac) activating histone marks, was
deposited on the viral episome and accompanied by the transient induction of a limited number of lytic genes.
Interestingly, temporary expression of the RTA protein facilitated the increase of H3K4me3 and H3K27ac occupancy on the
KSHV episome during de novo infection. Between 24–72 hours post-infection, as the levels of these activating histone marks
declined on the KSHV genome, the levels of the repressive H3K27me3 and H2AK119ub histone marks increased
concomitantly with the decline of lytic gene expression. Importantly, this transition to heterochromatin was dependent on
both Polycomb Repressive Complex 1 and 2. In contrast, upon infection of human gingiva-derived epithelial cells, the KSHV
genome underwent a transcription-active euchromatinization, resulting in efficient lytic gene expression. Our data
demonstrate that the KSHV genome undergoes a temporally-ordered biphasic euchromatin-to-heterochromatin transition
in endothelial cells, leading to latent infection, whereas KSHV preferentially adopts a transcriptionally active euchromatin in
oral epithelial cells, resulting in lytic gene expression. Our results suggest that the differential epigenetic modification of the
KSHV genome in distinct cell types is a potential determining factor for latent infection versus lytic replication of KSHV.
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Introduction
Kaposi’s sarcoma-associated herpesvirus (KSHV, Human
herpesvirus 8 or HHV-8) is one of the seven currently known
human tumor viruses and is associated with the pathogenesis of the
multifocal, angiogenic and inflammatory cancer called Kaposi’s
sarcoma (KS) and certain B cell-originated neoplasias, including
primary effusion lymphoma (PEL) and multicentric Castleman’s
disease (MCD) [1,2]. KSHV results in persistent infection in
immunocompetent humans by establishing latency in CD19+ B
cells [3]. The establishment of latency is the most fundamental
immune evasion strategy of KSHV, as the severely limited viral
gene expression characteristic of latently infected cells allows the
virus to escape detection by the host immune system. However,
immune suppression along with other environmental and physi-
ological factors can trigger the reactivation of KSHV from latency,
leading to the temporally ordered expression of viral genes and
release of infectious virus [4,5].
In KSHV-associated tumors, the majority of tumor cells harbor
KSHV in the latent phase and virus production is restricted to a
small population, indicating that it is the latently infected cells that
play a critical role in the development of KSHV-associated
cancers [6]. Indeed, the latent proteins of KSHV have several
important roles, such as the promotion of malignant transforma-
tion by facilitating the proliferation and survival of infected cells, as
well as the maintenance of the KSHV genome in dividing cells [7].
During latency, the KSHV genome exists as a circular episome in
the nucleus and adopts a nucleosome structure similar to the bulk
chromatinized cellular genome [8,9]. In this latent phase, the
latent genes of KSHV are continuously expressed, while the lytic
genes are repressed. Since chromatinization limits the access of
transcription factors to the promoter regions of viral genes,
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modification of the viral chromatin plays an essential role in the
control of viral gene expression. Based on the different combina-
tions of activating (acetylated H3K9/K14 or acH3 and
H3K4me3) and repressive (H3K9me3 and H3K27me3) histone
modifications that can be found on the chromatin of the KSHV
genome during latency, we have previously shown that the
chromatin of the viral episome is organized into distinct domains
[10,11,12].
One of the major cellular transcription repressors is the
Polycomb Repressive Complex 2 (PRC2), which is composed of
three core subunits (EZH2, EED and SUZ12) and can interact
with other transcription repressors, such as histone deacetylases
(HDACs), H3K4me3 demethylases and DNA methyltransferases
[13]. EZH2 catalyzes the trimethylation of histone H3K27, which
is one of the hallmarks of PRC2 function. We have previously
shown that both EZH2 and H3K27me3 are highly enriched on
lytic gene-coding regions of the KSHV genome during latency and
their association with the viral DNA decreases upon reactivation,
indicating that PRC2 plays a critical role in the repression of lytic
gene expression [11]. PRC2 often co-operates with another
polycomb group protein (PcG) complex called PRC1 in the
inhibition of cellular genes involved in cell proliferation, differen-
tiation and development. The enzymatic subunits of PRC1 are the
RING1A/B E3 ubiquitin ligases, which mono-ubiquitinate lysine
119 of H2A (H2AK119ub). This modification is thought to play a
role in chromatin condensation and transcription repression [14].
It has been shown that the PRC1 can be recruited to its target
promoters via the CBX protein, a subunit of PRC1 that binds to
H3K27me3, suggesting that PRC1 is recruited to its target loci in
a PRC2-dependent manner. However, there are at least six
different PRC1 complexes, and the RING1 and YY1 binding
protein (RYBP) DNA-binding factor-containing PRC1 can also be
recruited to several PcG target sites and repress cellular genes
independently of PRC2 [15,16]. Whether PRC1 is also recruited
to the KSHV genome during latency and contributes to the
repression of lytic genes has not yet been addressed.
Establishment of latency is an essential step for herpesvirus
persistent infection. KSHV can infect a variety of cell types where
it establishes latency in the majority of cases, suggesting that lytic
gene expression is constantly inhibited and only latent gene
expression is permitted [6]. Although the KSHV genome exists in
a linear and histone-free form in the viral capsid, upon infection, it
becomes a closed circular episome that subsequently associates
with cellular histones and persists as a non-integrated minichro-
mosome in the nucleus of infected cells [9,10]. Interestingly, it has
been shown that some lytic genes possessing immunomodulatory
or anti-apoptotic functions are temporarily expressed after
infection [17]. These observations prompted us to hypothesize
that the KSHV genome undergoes a dynamic transition from an
active to a repressive chromatin state following de novo infection,
which allows transient lytic gene expression prior to the
establishment of latency.
To investigate the molecular details of the ‘‘pre-latency’’ phase
of KSHV infection, we analyzed the recruitment of chromatin
regulatory factors onto the KSHV genome following de novo
infection. Based on our results, we propose that the KSHV
genome undergoes a biphasic chromatinization after de novo
infection. Initially, a transcriptionally active euchromatin, charac-
terized by high levels of H3K4me3 and acetylated H3K27
(H3K27ac), is deposited on the viral episome and is later switched
to the PcG protein-regulated heterochromatin. We show that both
PRC2 and PRC1 are involved in the inhibition of lytic gene
expression following de novo infection. Furthermore, while the
KSHV genome undergoes a temporally ordered euchromatin-to-
heterochromatin transition in infected endothelial cells, KSHV
adopts a transcriptionally active euchromatin form in oral
epithelial cells, resulting in lytic gene expression. Thus, we
hypothesize that the deposition of differential epigenetic modifi-
cations on the KSHV genome in distinct cell types potentially
determines whether KSHV infection results in latent or lytic
replication.
Results
Gradual chromatinization of the KSHV genome following
de novo infection
We investigated how the chromatin of the latent KSHV
genome formed on the initially histone-free KSHV genome
following de novo infection. We primarily used SLK cells as a model
system for the de novo KSHV infection experiments for the
following reasons: (i) SLK cells are highly susceptible to KSHV
infection leading to the establishment of latency, which is thought
to be the default pathway of natural KSHV infection, (ii) SLK cells
support lytic replication upon treatment with chemical inducers or
the overexpression of the replication and transcription activator
protein (RTA) of KSHV, and (iii) the histone modification pattern
of KSHV chromatin in latently infected SLK cells significantly
resembles that in PEL cells [12,18]. Furthermore, we used the
recombinant KSHV BAC16 throughout the study that constitu-
tively expresses GFP [19]. FACS and immunofluorescence
analysis indicated that nearly 100% of SLK cells were GPF-
positive at 16–24 hours post-infection (hpi), showing the efficiency
of infecting SLK cells with KSHV (data not shown and Figure S1).
In order to investigate the chromatin assembly on the viral
genome following de novo infection, we performed FAIRE
(Formaldehyde-assisted isolation of regulatory elements) analysis,
which technique had been used to identify nucleosome depleted
regions in the KSHV genome [20] and histone occupancy
measurements on several KSHV promoters in SLK cells at 1, 8
and 24 hpi (Figure 1). Latently infected SLK cells that were
Author Summary
Although the KSHV genome is linear and chromatin-free in
the virions, it circularizes and adopts a repressive chroma-
tin structure in latently infected cells, inhibiting the
majority of viral gene expression. In this study, we
investigate the epigenetic regulatory mechanism of the
pre-latency phase of KSHV infection. We found that upon
de novo infection, the KSHV genome undergoes distinct
chromatin states in a temporally ordered manner prior to
the establishment of latency. Initially, the KSHV genome
carried a transcriptionally permissive chromatin structure
to allow expression of a subset of viral lytic genes.
Subsequently, cellular Polycomb Repressive Complex 1
(PRC1) and PRC2 were recruited to the KSHV genome,
resulting in the deposition of repressive histone marks
onto the viral chromatin and the accumulation of
heterochromatin structures, both of which were critical
for the establishment of viral latency. In contrast to the
biphasic chromatinization and genome-wide inhibition of
lytic genes observed in de novo-infected SLK and TIME
cells, KSHV adopts a transcriptionally permissive chromatin
form in human gingiva-derived epithelial cells, resulting in
prolonged and robust lytic gene expression. Thus, our
results suggest that the differential epigenetic modifica-
tion of the KSHV genome in distinct cell types is a potential
determining factor for latent infection versus lytic replica-
tion of KSHV.
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maintained for more than 6 months after initial KSHV infection
were used as a reference point to represent fully chromatinized
viral episomes. The selected viral promoters represent the gene
regulatory regions of the four kinetic classes of KSHV genes:
latency (LANA), immediate early (IE, RTA), early (E, K2) and late
(L, ORF25). The promoters of actin (ACT) and myelin
transcription factor 1 (MYT1) served as cellular controls. The
FAIRE assay is used for the separation of chromatin-free DNA
fragments from the chromatin-associated ones based on their
differential retention in the aqueous phase during phenol-
chloroform extraction. Chromatin-free DNA fragments in the
aqueous phase are subsequently purified and measured by real-
time quantitative PCR analysis. Figure 1A shows the relative
amounts of chromatin-free viral and cellular promoter DNA
fragments purified from infected cells at different time-points.
These results revealed that a significant proportion of the viral
promoters were initially chromatin-free, but they rapidly under-
went chromatinization and the degree of their chromatin
association ultimately became similar to that of the cellular genes
(Figure 1). Accordingly, the H3 and H2A histone occupancy of the
KSHV genome gradually increased shortly after de novo infection,
indicating the assembly of the KSHV genome into a nucleosome
structure, which ultimately resulted in comparable levels of histone
H3 and even higher enrichment of H2A on the viral genome
relative to the cellular genome (Figures 1B and C). Furthermore, in
accordance with previous findings [17], we detected transient
expression of lytic genes upon de novo infection and found higher
levels of lytic gene expression at 24 hpi compared to latently
infected cells (Figures 1D and S1). These data indicate that the
KSHV genome undergoes rapid chromatinization following
infection, suggesting that the initial burst of lytic gene transcription
likely originates from transcriptionally permissive chromatin rather
than naked DNA.
Temporally ordered deposition of activating and
repressive histone modifications on the KSHV genome
during de novo infection
In order to investigate whether the deposition of activating and
repressive histone marks on the KSHV genome occurs in a
spatially and temporally regulated manner following de novo
infection, we performed the ChIP assay on the KSHV genome
at 1, 4, 8, 16, 24 and 72 hpi in SLK cells (Figure 2). The
chromatin of the latent KSHV genome was used as a reference, as
previously described [12]. In addition, the histone modification
ChIPs were normalized for the total amount of relevant histone at
a given genomic region. The transcriptionally active promoter of
cellular actin (ACT) gene and the transcriptionally silenced
promoter of cellular Polycomb-targeted MYT1 gene were used
as controls to show the comparable efficacy of histone mark ChIPs
at each time point throughout the experiments. This time course
ChIP assay revealed a temporally ordered deposition of activating
and repressive histone modifications on the KSHV genome
following de novo infection. Specifically, the activating H3K4me3
Figure 1. De novo chromatinization of the KSHV genome following infection. (A) FAIRE assay showing the degree of chromatinization of
the indicated viral and cellular promoters in SLK cells infected for 1, 8 or 24 hours or in latently infected SLK cells. (B) and (C) The enrichment of
histones H3 and H2A was calculated as ChIP/input (% Input or occupancy) at the indicated viral and cellular promoters following de novo infection at
1, 8 and 24 hpi and in latently infected SLK cells. (D) Real time RT-PCR analysis was performed to determine the expression of the indicated viral
genes in SLK cells infected by KSHV for 8 and 24 hours and in latently infected SLK cells. Expression levels of viral genes are shown relative to those of
18S. A 2-tailed student’s t-test was performed between 8 hpi and latency for each tested lytic gene and all p values were less than 0.05.
doi:10.1371/journal.ppat.1003813.g001
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histone mark gradually increased on the latent (LANA), IE (RTA)
and E (K2) promoters, peaking at 24 hpi and then declining by
72 hpi, while the level of H3K4me3 on the L (ORF25) promoter
was considerably lower compared to those of other promoters at
all of the time points analyzed (Figure 2A). The H3K27 can be
either acetylated (H3K27ac), characteristic for transcriptionally
active genes, or mono- (H3K27me1), di- or trimethylated,
characteristic for transcriptionally inactive genes. H3K27ac was
detected on the latent, IE and E promoters as early as 1 hpi,
declined by 72 hpi and remained low on the IE and E promoters
during latency (Figure 2B). H3K27me1 significantly increased on
the lytic promoters, peaked at 8 hpi, and declined thereafter, while
Figure 2. Analysis of the deposition of histone modifications on KSHV promoters during de novo infection using time-course ChIP
assays. ChIPs were performed using latently infected SLK cells or SLK cells following de novo infection for the indicated hours post infection (hpi) and
the enrichment of histone modifications was measured by qPCR using primers specific for the indicated viral and cellular promoters. ChIPs for each
histone modification were normalized for the amount of the relevant histones at each promoter. T-test was applied to compare the values between
the indicated time points (*). (A) H3K4me3 ChIP (for LANA, RTA and K2 p,0.05, for ORF25 p = 0.1 between 1 and 24 hpi). (B) H3K27ac ChIP (for LANA
p = 0.6, RTA and K2 p,0.05, for ORF25 p = 0.18 between 1 and 72 hpi). (C) H3K27me1 ChIP (for LANA p = 0.063, for RTA, K2 and ORF25 p,0.05
between 1 and 8 hpi). (D) H3K27me3 ChIP (for LANA p = 0.33, for RTA, K2 and ORF25 p,0.005 between 1 and 72 hpi). (E) H2AK119ub ChIP (for LANA
p = 0.3, for RTA, K2 and ORF25 p,0.02 between 1 and 72 hpi). (F) Sequential deposition of H3K27ac and H3K27me1 on viral promoters during
infection was confirmed by sequential ChIP assays. The first ChIP was performed with H3K27ac-specific antibody at 1 hpi and 8 hpi, followed by
elution of the immunoprecipitated DNA, The eluted DNA was used as the input for a second ChIP performed with H3K27me1 antibody. (G)
Sequential deposition and colocalization of H3K4me3 and H3K27me3 on the RTA promoter following de novo infection were confirmed by sequential
ChIP assays. The first ChIP was performed with H3K4me3-specific antibody at 24 hpi and 72 hpi followed by the second ChIP for H3K27me3 using the
eluted first ChIPs as the input.
doi:10.1371/journal.ppat.1003813.g002
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H3K27me3 started to increase on lytic promoters at 24 hpi, and
reached a level comparable to that seen on the latent genome by
72 hpi (Figure 2C and D). As shown with repressed cellular genes
where the PRC2-mediated H3K27me3 often coexists with the
PRC1-mediated H2AK119ub histone modification, the
H2AK119ub was also enriched on the lytic promoters in
conjunction with H3K27me3 (Figure 2E). The levels of these
histone modifications on the cellular promoters (ACT and MYT1)
remained similar in the course of de novo infection, suggesting that
the histone modification changes specifically occur on the viral
genome (Figure 2A–E). In addition, we showed that the temporally
ordered deposition of activating and repressive histone marks on
the KSHV genome was not restricted to the infected SLK cells, as
it was also detected in de novo-infected TIME cells (Figure S2).
To determine whether the temporally ordered deposition of
histone marks occurs on the same KSHV episome, sequential
ChIP assays were applied. In the first set of experiments, H3K27ac
ChIP was performed initially at 1 hpi and 8 hpi, followed by the
elution of the immunoprecipitated chromatin for use in a second
ChIP with anti-H3K27me1 antibody (Figure 2F). ChIP DNAs
were quantified by qPCR using specific primers for the promoters
of RTA and LANA genes. This showed that H3K27me1 coexisted
with H3K27ac on the same viral genome at 8 hpi. In the second
set of sequential ChIPs, H3K4me3 ChIP was performed at 24 and
72 hpi, followed by second ChIPs with anti-H3K27me3 antibody
(Figure 2G). These results showed that the RTA promoter carried
a high level of H3K4me3 and a low level of H3K27me3 at 24 hpi,
whereas a large amount of H3K27me3 was deposited onto the
RTA promoter associated with a low level of H3K4me3 at 72 hpi
(Figure 2G). In contrast, the H3K4me3-enriched LANA promoter
remained relatively H3K27me3-free (Figure 2G). This finding is in
accordance with the previous findings that the RTA promoter
possesses a bivalent chromatin, evidenced by the presence of both
activating and repressive histone modifications on this promoter
during latency [11,12]. Taken together, our results show that
KSHV undergoes different chromatin states upon de novo infection
before it adopts the H3K27me3/H2AK119ub-enriched hetero-
chromatin characteristic of latency. Specifically, the viral genome
has a transcriptionally permissive chromatin immediately after
infection, which is then switched to transcriptionally repressive
chromatin. In addition, the switch from active to repressive
chromatin is concurrent with the inhibition of lytic gene
expression.
Dynamic and global changes of histone modifications on
the KSHV genome following de novo infection
In order to obtain a genome-wide and comprehensive view of
the changes in viral chromatin that occur following de novo
infection, a series of ChIP-on-chip experiments was performed.
We mapped the genome-wide deposition of the activating histone
marks, H3K27ac and H3K4m3, and the repressive histone mark,
H3K27me3, on the KSHV genome in SLK cells at 4, 24 and
72 hpi (Figure 3A). For this, we used our KSHV-specific 15-bp
tiling microarray, which contains 60 nucleotide-long oligos
covering the entire KSHV genome and enables high resolution
mapping of histone marks on the viral genome [11]. Based on the
genome-wide ChIP data, we generated a heat map that offered a
close-up view of the chromatin structure of the regulatory regions
of KSHV genes and quantified the changes that occurred in these
regions following de novo infection (Figure 3B). For this, we plotted
the signal intensities of probes derived from the ChIP-on-chip
analysis at 1 kb upstream and 1 kb downstream of the transla-
tional start site (TSS), as previously described [11]. The rationale
of this strategy is based on the considerations that (i) due to the
compact structure of the KSHV genome, the promoters are
generally closely localized upstream of the TSS and (ii) the distinct
modification of histones in the 59 region of the gene bodies usually
plays a role in the regulation of gene expression.
ChIP-on-chip experiments revealed highly dynamic and global
changes in the posttranslational modifications of the viral
chromatin following de novo infection (Figure 3). In agreement
with our initial gene-specific ChIP experiments, we found that
while activating histone marks were detected on the viral
chromatin as early as 4 hpi, the repressive H3K27me3 histone
mark was completely absent at an initial stage. Furthermore, our
analyses revealed that the genome-wide enrichment of the
activating histone marks H3K27ac and H3K4me3 highly corre-
lated with each other on the KSHV genome throughout infection
(Table S2 and Figure 3). The high Pearson correlation of the
enrichment of H3K27me3 on the KSHV genome between 24 hpi
and 72 hpi indicated that EZH2 was targeted to those genomic
regions as early as 24 hpi, where the H3K27me3-rich chromatin
domain would ultimately be established at 72 hpi (Table S2). In
addition, our analysis indicated that the histone modification
changes on the viral genome were highly gene specific: (i) The
latency locus, which encodes constitutively expressing genes, such
as ORF73/LANA, adopted activating histone modifications
H3K27ac and H3K4m3 during de novo infection. (ii) While the
activating histone marks were initially enriched at a few IE (K4.2,
ORF48 and ORF50/RTA and E lytic genes (e.g. K2, K3, K4,
K5, K6 and vIRF1) at 4 hpi, this enrichment expanded to nearly
all lytic genes at 24 hpi, and subsequently declined concomitantly
with the increased enrichment of the repressive histone mark
H3K27me3 occurring between 24 and 72 hpi. (iii) Interestingly,
the gene regulatory regions of IE and E genes (e.g. K5, K6, K7,
ORF74 and vIRF1) were largely devoid of H3K27me3 at 24 hpi,
where both H3K4me3 and H3K27ac were highly enriched. (iv)
While the enrichment of H3K27ac was dramatically reduced and
restricted to a few genes (e.g. ORF73, K4.2, K4, K5, K6 and
vIRF1) by 72 hpi, a high level of H3K4me3 remains at several
genomic regions (e.g. 15–30 kb, 70–90 kb) mainly encoding IE
and E lytic genes. (v) Genomic regions encoding a large number of
late genes (e.g. 30–60 kb and 95–115 kb) showed low levels of
activating histone modifications at 72 hpi and were enriched with
the repressive histone mark, H3K27me3. These results indicate
that the majority of the KSHV genome undergoes a biphasic
euchromatin-to-heterochromatin transition after de novo infection.
RTA facilitates the deposition of activating histone
modifications on the viral genome following de novo
infection
Previous studies have shown that a subset of lytic genes,
including RTA, is temporarily expressed following de novo infection
[17]. To address whether the transient expression of RTA plays a
role in the regulation of chromatinization of the KSHV genome
during de novo infection, we infected SLK cells with either wild type
(wt) or RTA knockout (RTAstop) KSHV [21] and performed
ChIP assays for H3K4me3, H3K27ac and H3K27me3 at 8, 24
and 72 hpi. Interestingly, the levels of both H3K4me3 and
H3K27ac were significantly lower on several lytic promoters at
8 hpi in RTAstop virus-infected cells relative to WT virus-infected
cells, while the deposition of H3K27me3 was similar in both cells
(Figure 4A). In contrast, the levels of these histone modifications
were comparable on the LANA promoter and the cellular ACT
and MYT1 promoters in WT virus- vs. RTAstop virus-infected
cells (Figure 4A). Consequently, the transient induction of lytic
genes (K2, K6, K7, ORF46 and vIRF2) was lower in RTAstop
virus-infected cells compared to WT virus-infected cells
Chromatinization of the KSHV Genome
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(Figure 4B). Since RTA has been shown to bind to its responsive
viral promoters (e.g. RTA and K2) and recruits CBP, the histone
acetyltransferase of H3K27ac [22], we also performed ChIP assays
for RTA and CBP and found that both RTA and CBP bound to
the RTA and K2 promoters following de novo infection, but not
during latency, whereas their binding was not observed on the
ORF25 promoter, which lacks RTA responsive elements
(Figure 4C). Furthermore, while CBP-binding to the RTA and
K2 promoters was abolished in RTAstop KSHV-infected cells, it
was still detected on the LANA promoter possessing the H3K27ac
mark (Figure 4D). These data indicate that CBP can be recruited
to the KSHV genome by two distinct mechanisms. The KSHV
RTA recruits CBP to its responsive lytic promoters following de
novo infection and thereby facilitates the deposition of activating
histone marks on the KSHV genome. Alternatively, CBP can be
recruited to the KSHV genome independently of RTA.
Overexpression of RTA during de novo infection results in
constitutive lytic replication of infected KSHV
While KSHV RTA is sufficient to induce robust expression of
lytic genes and completion of a full cycle of lytic replication
[11,23], its temporal expression during de novo infection leads only
to the transient expressions of a few lytic genes prior to the
establishment of latency [17]. Therefore, we asked whether the
continuous expression of RTA during de novo infection affected the
chromatinization of the viral genome. Doxycycline (Dox)-induc-
ible RTA-expressing iSLK cells [18] were pre-treated with Dox for
8 hours, followed by KSHV infection for 24 and 72 hours.
Indeed, continuous RTA expression during de novo infection not
only led to the induction of lytic gene expressions and full-scale
viral replication (Figure S3A, B and C), but also reduced
chromatinization of the replicating KSHV genome, evidenced
by the reduction of histones H3 and H2A occupancy on the
KSHV promoters (Figure S3D). These data indicate that, unlike
overexpression of RTA, the transient expression of RTA during de
novo infection may not be sufficient to induce the full lytic gene
expression program.
PRC2 and PRC1 complexes bind to the KSHV genome
and promote the inhibition of lytic genes following de
novo infection
The deposition of both repressive histone modifications,
H3K27me3 and H2AK119ub, on the KSHV genome during de
novo infection indicates that both PRC2 and PRC1 are recruited
onto the viral episome. To test the binding of the PRC complexes
Figure 3. Genome-wide view of the deposition of histone modifications on the KSHV genome following de novo infection. (A) ChIP-
on-chip was performed for H3K27ac, H3K4me3 and H3K27me3 at 4, 24 and 72 hpi using SLK infected cells. The alternating dark and light blue
squares represent viral ORFs. (B) Heat map representation of changes in histone modifications at the gene regulatory regions of KSHV genes grouped
by expression class (latent, La, immediate-early, IE, early, E, late, L). The rows display the relative abundance of the indicated histone modification
within the 21 kb to +1 kb genomic regions flanking the translational start site (TSS) of each viral gene. The blue and yellow colors denote lower-
than-average and higher-than-average enrichment, respectively, whereas gray represents missing values for enrichment due to lack of probes in
those genomic regions.
doi:10.1371/journal.ppat.1003813.g003
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on the viral genome, we performed ChIPs for the PRC2 subunit,
EZH2, and the PRC1 subunits, RING1B and RYBP, in infected
SLK cells at 4, 24, 72 hpi and again used latently-infected SLK
cells as a reference. The results showed that each PcG subunit was
readily detected on the promoters of the lytic genes (RTA, K2 and
ORF25) at 72 hpi and during latency, while they were not
recruited to the LANA promoter at any of the time points
(Figure 5A). In order to demonstrate the genome-wide binding of
Figure 4. RTA is involved in the deposition of activating histone marks on the KSHV genome following de novo infection. (A)
Comparative ChIP analysis of H3K4me3, H3K27ac and H3K27me3 at the indicated viral promoters of wild type (wt) or RTA knockout (RTAstop) KSHV-
infected SLK cells at 8, 24 and 72 hpi. The promoters of the cellular actin (ACT) and MYT1 genes were used as controls. ChIPs were normalized for the
amount of histone H3 at each promoter. The asterisk denotes p,0.05 between wt and RTAstop at 8 hpi. (B) RT-qPCR analysis of viral gene expression
in RTAstop KSHV-infected SLK cells at 24 hpi. The expression of the indicated viral genes was calculated relative to wt KSHV-infected cells. (C) ChIP
experiments showing the binding of RTA and CBP on the RTA-responsive RTA and K2 promoters as well as the LANA promoter in latently-infected
cells and naı¨ve cells infected for 8 or 24 hours by wild type KSHV. ORF25 promoter was used as a negative control. (D) RTA and CBP binding on viral
promoters in RTAstop KSHV-infected SLK cells.
doi:10.1371/journal.ppat.1003813.g004
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the PRC2 and PRC1 complexes, we performed ChIP-on-chip for
the EZH2 and RING1B PRC subunits in SLK cells at 4 and
72 hpi (Figures 5B and S4). This showed that EZH2 and RING1B
were barely detected on the KSHV genome at 4 hpi, while they
were highly enriched on the viral genome with an extensive
co-occupancy at 72 hpi (Pearson correlation 0.6). To further
address whether they contributed to the inhibition of lytic
replication following de novo infection, we measured lytic gene
expressions upon the shRNA-mediated depletion of either EZH2
or RING1B in SLK cells at 72 hpi. Immunoblot analysis indicated
that the gene-specific shRNA treatments robustly reduced
endogenous EZH2 and RING1B levels (Figure 6A). RT-PCR
analysis showed that shRNA-mediated depletion of EZH2 or
RING1B resulted in the induction of viral gene expression similarly
to that of the PRC cellular target gene, MYT1 (Figure 6B).
Because a functional PRC2 complex has been shown to be
required for the recruitment of PRC1 complex to the majority of
PcG target genes, we tested whether the recruitment of PRC1 to
the KSHV genome also depended on the PRC2 function.
shEZH2-treated SLK cells were infected with KSHV and
subjected to ChIP assays at 72 hpi (Figure 6C). shRNA-mediated
depletion of the EZH2 led to the significant decline of H3K27me3
on lytic promoters, which resulted in the reduction of RING1B
recruitment and H2AK119ub deposition (Figure 6C). In contrast,
the levels of activating histone marks, H3K27ac and H3K4me3,
were increased upon these conditions (Figure 6C). Furthermore,
Figure 5. Recruitment of components of the PRC2 and PRC1 complexes onto the KSHV genome during de novo infection. (A) Time-
course ChIP analysis of the binding of EZH2 (PRC2), RING1B and RYBP (PRC1) onto KSHV promoters at 4, 24, and 72 hpi and during latency. (B)
Genome-wide recruitment of EZH2 and RING1B to the KSHV genome at 4 and 72 hpi. The Pearson correlation between the binding of EZH2 and
RING1B is 0.6 at 72 hpi. Labels are the same as in Figure 3.
doi:10.1371/journal.ppat.1003813.g005
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treatment by GSK343, a novel and specific EZH2 inhibitor [24],
efficiently reduced the H3K27me3 levels without affecting the
expression of EZH2 and also increased the H3K27ac levels
(Figure 6D). ChIP assays also showed that GSK343 treatment
resulted in the reduction of EZH2 recruitment and H3K27me3
levels on KSHV lytic promoter regions, which was accompanied
by the decrease of RING1B recruitment and the increase of the
activating histone mark H3K27ac (Figure 6E). Consequently, the
GSK343-mediated inhibition of EZH2 increased the expression of
KSHV lytic genes following de novo infection of various cell types
(Figures 6F and S5A). Finally, we examined the effect of
GSK343 treatment on de novo infection of 293T cells with
rKSHV.219, a recombinant virus that expresses the green
fluorescent protein (GFP) from the cellular EF-1a promoter and
the red fluorescent protein (RFP) during lytic replication from
the viral early PAN promoter [25]. This showed that GSK343
treatment resulted in significant increase of RFP expression
compared to control cells (Figure S5B and C). These data
collectively show that both PRC2 and PRC1 complexes bind to
the KSHV genome and mediate the inhibition of lytic gene
expression following de novo infection.
Transcriptionally permissive chromatin assembly on the
KSHV genome following de novo infection of oral
epithelial cells
While KSHV results in latent infection in most cell types, oral
epithelial cells have been reported to support lytic replication
following de novo infection [26]. To test whether the KSHV
genome undergoes a distinct chromatinization in oral epithelial
cells compared to other cell types, we used three different oral
epithelial cells for KSHV infection: OEPI E6/E7-immortalized
human gingiva-derived epithelial cells, SCC15 human tongue
squamous carcinoma cells and primary normal oral keratinocytes
(NOK) cells. The susceptibility of these oral epithelial cell lines to
KSHV infection was comparable with that of SLK cells based on
GFP-positivity, analyzed using immunofluorescence and FACS
analyses (Figure S6A and data not shown). When SLK, OEPI,
SCC15 and NOK cells were infected with KSHV for 4, 24, 48
and 72 hours and measured for the viral DNA loads at each time
point, KSHV replication was only detected in OEPI-infected cells
and this increase in viral DNA load was sensitive to inhibition by
the viral DNA polymerase inhibitor phosphonoacetic acid (PAA)
(Figure 7A). Accordingly, the FAIRE assay showed that while
KSHV was initially chromatinized in infected OEPI cells at 8 and
24 hpi, the viral DNA became chromatin-depleted during
replication (Figure 7B). The induction of KSHV gene expression
in infected OEPI cells was confirmed by immunoblotting for the
lytic KSHV proteins, RTA and K3 (Figure 7C), by quantitative
RT-PCR for several other lytic genes (Figure 7D), and by
immunostaining for K3 expression (Figure S6). ChIP analysis of
infected OEPI cells revealed increasing euchromatinization
(H3K4me3 and H3K27ac) on the representative latent (LANA),
IE (RTA), E (K2) and L (ORF25) promoter regions, but a lack of
efficient deposition of heterochromatin histone marks (H3K27me3
and H2AK119ub) on these regions (Figures 7E and F). While
OEPI, SCC15 and NOK cells were efficiently infected by KSHV
(Figure S6A), the expression of Polycomb proteins was lower in
Figure 6. Both PRC2 and PRC1 are involved in the inhibition of lytic gene expression following de novo infection. (A) Immunoblot
analysis of EZH2 and RING1B expression in shRNA-treated SLK cells. (B) RT-qPCR analysis of viral gene expression of KSHV infected cells upon
depletion of EZH2 and RING1B expression. The expression of viral genes and MYT1 cellular gene is shown relative to that of KSHV infected SLK cells
treated with scrambled shRNA. (C) ChIP assays show that depletion of the EZH2 expression during de novo infection altered the deposition profiles of
histone modifications and led to the reduction of RING1B recruitment on the KSHV genome. The asterisk denotes p,0.02. (D) Following 2 days of
treatment with either DMSO or the EZH2 inhibitor, GSK343, SLK cell lysates were used for immunoblot analysis with the indicated antibodies. (E) ChIP
analysis of the recruitment of PcG proteins and the deposition of histone modifications on KSHV promoters in KSHV infected cells pretreated with
GSK343. (F) GSK343-treated TIME, SLK and 293T cells were infected by KSHV for 72 hours and RT-PCR was performed to test the expression of viral
genes and the cellular gene MYT1. The fold change represents the induction of viral gene expression in GSK343-treated cells compared to DMSO-
treated cells.
doi:10.1371/journal.ppat.1003813.g006
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OEPI cells than in NOK and SCC15 cells (Figure 7G), and the
higher level of KSHV replication was detected only in OEPI cells.
This indicates that the weak expression of PcG proteins correlates
with the high level of KSHV replication in OEPI cells. This
suggests that the weak expression of the EZH2, SUZ12 and
RING1B PRC subunits may result in inadequate deposition of
H3K27me3 and H2AK119ub on the lytic promoters of infected
OEPI cells, resulting in the activation of lytic gene expression. It
should be noted that despite the viral DNA replication in OEPI
cells following de novo infection, we did not detect infectious virus
particles, suggesting that additional factors downstream of viral
DNA replication may prevent the production of infectious virions.
Taken together, these data suggest that the differential
epigenetic modification of the KSHV genome in distinct cell
types may determine whether KSHV establishes latent or lytic
gene expression program following de novo infection.
Discussion
While the KSHV genome is histone-free in the virions, the viral
DNA adopts a highly organized chromatin structure in latently
infected cells, which is an essential step in establishing the latency-
associated viral gene expression program necessary for persistent
infection of the host [10]. A previous study by Gunther and
Grundhoff has shown that at 5 days after infection of SLK cells,
KSHV adopts a highly structured chromatinized episome that
resembles the viral chromatin structure found in latently infected B
cell lymphoma cells [12]. Here, we demonstrate that the latent
chromatin structure of KSHV gradually develops following de novo
infection and is fully established as early as 3 days post-infection.
Based on our results, we propose that the KSHV genome
undergoes a spatially and temporally ordered chromatinization
following de novo infection prior to the establishment of latency
(Figure 8). We demonstrated that the viral DNA rapidly associates
with histones after infection and that initially, there is a transient
enrichment of H3K4me3 and H3K27ac activating histone marks
on the viral chromatin and concomitant expression of lytic genes.
This is followed by the decline of activating histone marks and the
transition from a transcriptionally active viral chromatin to a
H3K27me3/H2AK119ub-enriched heterochromatin, a transition
that is regulated by the PRC2 and PRC1 cellular transcription
repressor complexes and ultimately results in the inhibition of lytic
gene expression and the establishment of latency (Figure 8). Thus,
our results indicate that the KSHV genome undergoes a biphasic
chromatinization after de novo infection prior to the establishment
of latency.
Our previous study has shown that the distinct chromatin
domains of the latent KSHV genome are characterized by
Figure 7. Euchromatinization of the KSHV genome in gingival oral epithelial cells following de novo infection. (A) Measurement of viral
DNA replication in SLK, OEPI, SCC15 and NOK cells infected by KSHV for 4, 24, 48 and 72 hours. The viral DNA polymerase inhibitor, PAA, was applied
to block the replication of KSHV. (B) FAIRE assay showing the degree of chromatinization of the indicated viral and cellular promoters in SLK and OEPI
cells infected for 8, 24 or 72 hours. (C) SLK and OEPI cells were infected with KSHV for 1, 2 and 3 days and immunoblots were performed to test the
expression of RTA and K3 viral proteins. Actin served as a loading control. The ‘‘C’’ indicates immunoblot analysis of uninfected cells. (D) Quantitative
RT-PCR analysis of viral gene expression in KSHV infected SLK and OPEI cells. (E) and (F) ChIP analysis of the indicated histone modifications on a
selection of KSHV promoters in OEPI cells at 8, 24 and 72 hpi. The cellular promoters (ACT and MYT1) were used as controls. (G) Comparative
immunoblot analysis of the indicated cellular proteins between SLK and oral epithelial cells.
doi:10.1371/journal.ppat.1003813.g007
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different combinations of histone modifications [10,11,12]. The
results of this study show that the KSHV genome undergoes a
specific biphasic euchromatin-heterochromatin transition upon de
novo infection. Both studies indicate that activating and repressive
histone marks are enriched only on specific viral genomic regions
in the early stage of infection and during latency. For example, the
deposition of H3K27me3 is always excluded from the latency-
associated locus but enriched on lytic genes-encoding regions
throughout both de novo infection and latency (Figures 2 and 3).
Also, the deposition of H3K4me3 occurs mainly on latent genes
and some IE/E genes at 4 hpi and during latency. These findings
indicate targeted recruitment of specific histone-modifying enzyme
complexes to different sites of the KSHV genome from the
beginning of infection, a process that is likely orchestrated by
sequence-specific DNA-binding factors. These factors might be,
for example, the CTCF/cohesin complex, which is involved in the
regulation of nuclear organization of the KSHV chromosome or
RBP-Jk, which controls viral transcription by binding to many
KSHV promoters [27,28]. Additional studies will be required to
demonstrate how the positions of these chromatin domains are
specifically determined on the KSHV genome and what types of
DNA-binding factors are involved in the recruitment of chromatin
regulatory complexes onto the KSHV genome.
Our data also show that the deposition of activating and
repressive histone marks on the KSHV genome occurs in a
temporally ordered manner following de novo infection. One of the
striking examples of this is the differential modification of H3K27
(Figure 2). In mammalian cells, H3K27 can either be acetylated by
the histone acetyltransferases CBP/p300 or mono-, di-, or
trimethylated by EZH2 [29]. By using sequential ChIP assays,
we found that the acetylation of H3K27 is followed by its gradual
switch to methylation on the same KSHV genome, indicating the
sequential action of different histone modifying enzymes on the
same viral genome following de novo infection. We also observed
that the decrease of H3K27ac on lytic promoters resulted in
increasing levels of H3K27me3 in a coordinated manner, further
supporting that the histone modifying enzymes are recruited to the
KSHV genome in a temporally ordered manner following de novo
infection.
Because the KSHV genome is initially chromatin-free following
infection, the viral promoters are easily accessible by the RNAPII
transcription machinery to induce viral transcription, which might
explain the transient expression of lytic genes during de novo
infection (Figure 1) [17]. RNAPII has been shown to interact with
H3K4me3 histone methyltransferases and the H3K27me3
demethylase JMJD3 [30,31,32,33]. Therefore, these histone
Figure 8. Biphasic euchromatin-to-heterochromatin transition on the KSHV genome following de novo infection. As soon as the viral
genome enters the nucleus, histones are recruited on the viral DNA, resulting in the chromatinization of the KSHV genome. The viral genome initially
adopts a transcriptionally permissive chromatin, characterized by high levels of the H3K27ac and H3K4me3 and this is accompanied by the transient
expression of lytic genes. Subsequently, the PRC2 and PRC1 are recruited to viral genome, where they are responsible for the enrichment of
H3K27me3 and H2Ak119ub on the viral chromatin as well as the repression of lytic genes. During latency, both PRC2 and PRC1 remain on the KSHV
genome for the maintenance of the repression of lytic genes.
doi:10.1371/journal.ppat.1003813.g008
Chromatinization of the KSHV Genome
PLOS Pathogens | www.plospathogens.org 11 December 2013 | Volume 9 | Issue 12 | e1003813
modifying enzymes might be recruited onto lytic promoters by
RNAPII and thereby contribute to the deposition of histone
modifications on the viral chromatin during de novo infection. In
addition, viral proteins expressed during de novo infection can also
be involved in the modulation of the evolving viral chromatin
structure. Indeed, we found that the transient expression of the
lytic protein RTA had a significant effect on the deposition of
activating histone modifications on lytic promoters. In the absence
of RTA, the level of both H3K4me3 and H3K27ac was
significantly lower on the KSHV genome after infection and this
was accompanied by the reduced expression of several lytic genes
(Figure 4). RTA binding to lytic promoters also recruited CBP, the
histone acetyltransferase of H3K27ac to lytic promoters during de
novo infection. These data suggest that the RNAPII transcription
machinery and the viral transcription factor RTA may promote
the deposition of activating histone marks on the KSHV genome
during de novo infection, contributing to the temporal induction of
lytic genes.
RTA is a potent viral transcription factor, which is sufficient for
the induction of the lytic gene expression program in infected cells
[34]. However, upon de novo infection, KSHV usually does not
undergo lytic replication, even though RTA is expressed. This
might be due to the weak endogenous promoter of RTA, which
seems to be prone to repression and thus, it is unable to sustain its
continuous expression after infection. Indeed, heterochromatin-
associated cellular factors such as the PRC2 complex, HDACs and
transcription repressor KAP-1 have been shown to be recruited
onto the RTA promoter, leading to the silencing of the promoter
[8,11,35]. On the other hand, KSHV infection of RTA-expressing
cells (Figure S3) or infection of cells with a recombinant KSHV
constitutively expressing RTA [36] resulted in efficient lytic
replication. Thus, these data indicate that the temporal expression
of RTA during de novo infection may not be sufficient to induce the
full cycle of KSHV lytic replication, thereby leading to the
establishment of latency.
We have previously shown that PRC2 is involved in the
repression of lytic genes during latency [11,12]. Here, we have
found that the PRC1 complex is also recruited onto the KSHV
genome and both PRCs are involved in the repression of lytic
genes following de novo infection (Figures 5 and 6). Furthermore,
while PRC1 was preferentially recruited onto the lytic gene
promoters via H3K27me3 pre-deposited by PRC2, PRC1 may
also bind to specific lytic gene regions independently of PRC2 via
its RYBP DNA-binding factor [15]. We found that, during de novo
infection, the binding of RYBP on the viral genome precedes that
of EZH2, indicating a sequential recruitment of PcG proteins,
where RYBP may recruit PRC1 independently of PRC2 at
specific lytic promoters (Figure 5). These PRCs have been shown
to be recruited to their cellular target loci by various non-coding
RNAs and distinct transcription factors [13]. Thus, it would be
intriguing to determine what host or viral factors are responsible
for the recruitment of PRCs on the KSHV episome during de novo
infection and latency.
Surprisingly, while KSHV infection results in latency in most
cell types, we found that in infected human OEPI cells, the KSHV
genome acquires H3K4me3/H3K27ac-enriched chromatin,
which is accompanied by lytic replication (Figure 7). Interestingly,
the expression of both EZH2 and RING1B was lower in OEPI
cells compared to SLK and NOK cells, likely contributing to the
reduced level of H3K27me3 and H2AK119ub on the KSHV
genome in OEPI cells. This suggests that the levels of chromatin
regulatory factors that KSHV encounters during infection of host
cells may influence the outcome of viral infection. However,
overexpression of EZH2 alone in OEPI cells was not sufficient to
force KSHV to establish latency (unpublished results). It is possible
that all or most of the components of PRC complexes must be
overexpressed in a specific ratio or additional repressors, other
than PRC complexes, are required for the establishment of KSHV
latency.
Establishment of latency is a common feature of all herpesviruses
and is characterized by the silencing of lytic genes and the inhibition
of viral replication [37]. Emerging evidence shows that Polycomb
proteins are involved in the repression of some lytic genes of Herpes
simplex virus type 1 (HSV-1) [38,39], Human cytomegalovirus
(HCMV) [40] and Epstein-Barr virus [41,42]. These observations
indicate that PRCs may function as part of a common intrinsic
immunity defense system against all herpesviruses, wherein they act
as inhibitors of viral replication and gene expression. The incoming
viral genomes of HSV-1 and HCMV have also been shown to
rapidly associate with histones following de novo infection [43,44]. As
with KSHV infection of oral epithelial cells, the viral chromatin of
HSV-1 and HCMV is enriched in activating histone marks,
facilitating lytic replication [45]. However, the regulation of
chromatinization of the HSV-1 and HCMV genomes during the
establishment of latent infection has yet to be studied.
In summary, our results are the first comprehensive study showing
that, following de novo infection of different cell types, the KSHV
genome undergoes a well-orchestrated transition between distinct
chromatin states and that this process is regulated by site-specific
recruitment of chromatin regulatory factors onto the KSHV genome.
Because of the compact size of its genome and the presence of several
unique viral DNA sequences, KSHV may use a specific set of
transcription and chromatin regulatory factors to regulate its viral
chromatin structure. Therefore, the identification of the relevant
cellular and viral proteins involved in the regulation of chromatin
structure of KSHV can lead to the discovery of new therapeutic
targets for controlling KSHV infection and pathogenesis.
Materials and Methods
Cells, viruses and de novo infection
293T and SLK cells were maintained in DMEM medium
supplemented with 10% FBS, 100 U/ml penicillin and 100 mg/ml
streptomycin (P/S). TIME cells were cultured in VasculoLife
VEGF medium according to the manufacturer’s specifications
(Lifeline Cell Technology). The generation of the iSLK cell line is
described elsewhere [18]. iSLK cells were cultured in DMEM
medium supplemented with 10% FBS, P/S, 1 mg/ml puromycin
and 250 mg/ml G418. The iSLK cell lines carrying BAC16 or
BAC16RTAstop were maintained in the presence of 1 mg/ml
hygromycin. The construction of BAC16RTAstop virus was
described previously [21]. NOK (gift from Yang Chai, USC),
SCC15 (ATCC) and gingival OEPI epithelial cell lines were
cultured in Keratinocyte-SFM medium (Gibco) according to the
manufacturer’s instructions. The primary gingival epithelial cell
line was a generous gift from Jennifer Webster-Cyriaque (UNC,
Chapel Hill), which was immortalized by the papillomavirus E6/
E7 to make OEPI. KSHV was prepared from iSLKBAC16 and
iSLKBAC16RTAstop cell cultures by treatment with 1 mg/ml
doxycycline and 3 mM sodium butyrate and the viral titer was
calculated as described previously [21]. De novo infection was
performed by spin-infection using a MOI of 1 (2000 rpm, 45 min
at 30uC). After infection the media was changed and the infected
cells were harvested at the indicated time points.
Antibodies and inhibitors
The following antibodies were used in ChIPs and/or immunoblots:
rabbit anti-histone H3 (Abcam ab1791), rabbit anti-H3K27me1
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(Millipore 07-448), rabbit anti-H3K27me3 (Millipore 07-448, Active
Motif 39155 and Cell Signaling 9756), rabbit anti-H3K4me3
(Millipore 04-745 and Active Motif 39159), rabbit anti-H2A (Millipore
07-146), rabbit anti-H2AK119ub (Cell Signaling 8240), rabbit anti-
H3K27ac (Abcam ab4729), mouse anti-BMI1 (Millipore 05-1322),
rabbit anti-CBP (sc-369), rabbit anti-RING1B (Abcam ab101273),
mouse anti-EZH2 (BD Biosciences 612666), rabbit anti-SUZ12
(Abcam ab12073), rabbit anti-RYBP (Abcam ab5976), rabbit anti-
Spt5 (sc-28678) and mouse anti-actin (Abcam). The rabbit anti-RTA
antibody was a generous gift from Drs. Yoshihiro Izumiya and Hsing-
Jien Kung (UC Davis, Sacramento). LANA and K3 KSHV protein-
specific antibodies have been described previously [11]. GSK343 was
obtained from Structural Genomics Consortium (Toronto, Canada).
GSK343 was used at 50 mg/ml in cell culture.
ChIP and ChIP-on-chip assays
ChIPs and ChIP-on-chips were performed as have been
published previously, with a few modifications [11]. The primer
sequences used in ChIP-qPCR are listed in Table S1. ChIP graphs
show the average of at least two independent experiments. For
ChIP-on-chip, 10 mg of chromatin and 2 mg of antibodies were
used for each reaction. The ChIP-on-chips were performed with a
custom-designed Agilent tiling microarray, as described previously
[11]. Briefly, amplified ChIP DNA and input DNA samples (2 ug)
were submitted to the UC Davis Comprehensive Cancer Center
Genomics Shared Resource for target labeling (Cy3, Cy5), array
processing, and microarray scanning. Raw image files were
processed with Agilent Feature Extraction software (version
10.5.1.1) to quantify feature signal intensities and to perform
normalization, dye bias correction, and background subtraction.
The raw data was pre-processed by blank subtraction (one-step
Tukey biweight subtraction) and intra-array (dye-bias) median
normalization in order to equalize the ChIP (Cy5) and input (Cy3)
DNA channels. Binding events, or enrichments, were represented
as increases in the ratios of the ChIP to input DNA signal
intensities. The ChIP-on-chip data is freely available at the GEO
repository (GSE51660). Data analysis of the 1 kb genomic region
surrounding the TSS of each viral gene was performed as
described in details previously [11]. The ChIP-on-chip data was
imported into Java TreeView (version 1.1.6r.4) for visualization.
FAIRE assay
Formaldehyde-assisted isolation of regulatory elements (FAIRE)
analysis was performed as described by Giresi et al with some
modifications [46]. DNA was purified from an equal amount of
formaldehyde-crosslinked and de-crosslinked chromatins, followed
by the quantification of DNAs via qPCR using viral or cellular
promoter specific primers. DNA purified from the formaldehyde-
crosslinked chromatin represents chromatin-free DNA, while DNA
derived from de-crosslinked chromatins is for the calculation of total
DNA. The ratio of chromatin-free and total DNAs shows the degree
of chromatinization of a given genomic DNA fragment in cells.
RNA purification and RT-qPCR
Total RNA was extracted from cells using Tri reagent (Sigma)
according to the manufacturer’s instructions. 1 mg of total RNA
was treated with DNase I (Sigma), reverse transcribed by iScript
cDNA Synthesis kit (Bio-Rad) and the cDNA was quantified by
qPCR using gene specific primers. The primer sequences are listed
in Table S1. The relative level of gene expression was calculated
by the 22dCt or the ddCt method, where either actin or 18S was
used for normalization. The RT-qPCR graphs represent the
average of at least two independent experiments.
Lentiviral shRNA knockdown
The pLKO.1 lentiviral vector was used to express the EZH2 and
RING1B specific shRNAs. Supernatants from 293T cells transfect-
ed by the shRNA and packaging vectors were collected 60 hours
post-transfection, followed by concentration of the virus
(24000 rpm, 1.5 hr, 4uC) and used for infection of cells in the
presence of 10 mg/ml polybrene. 2 days after lenti-shRNA infection,
the cells were split, and then infected with KSHV the following day.
Immunofluorescent analysis
Cells were fixed with 4% paraformaldehyde and then
permeabilized by 0.5% Triton X100. 10% FBS was used for
blocking nonspecific antibody binding, followed by incubation of
cells with antibodies against the KSHV protein K3. After
extensive washing with PBS, TRITC-conjugated secondary
antibody was applied, followed by Hoechst staining.
Supporting Information
Figure S1 Immunofluorescent analysis of SLK cells
infected with BAC16 KSHV for 8, 24 or 72 hours at
MOI of 1 and latently infected SLK cells.
(PPTX)
Figure S2 Analysis of the deposition of histone modifi-
cations on KSHV promoters during de novo infection of
TIME cells. ChIPs were performed at the indicated viral
promoters with TIME cells at 8, 24 and 72 hpi and with latently
infected TIME cells. Each histone modification ChIP was
normalized for the amount of the relevant histones at each
promoter as in Figure 2.
(PPTX)
Figure S3 Constitutive replication of KSHV in RTA-
expressing SLK cells. (A) Measurement of KSHV DNA
replication in Dox uninduced (2) and induced (+) iSLK cells at 24
and 72 hpi. (B) Immunoblot analysis of KSHV protein expression in
Dox-untreated or Dox-treated iSLK cells. (C) RT-qPCR test of
KSHV gene expression in Dox-untreated or Dox-treated iSLK cells.
(D) Recruitment of histones H3 and H2A on KSHV promoters in
Dox-untreated or Dox-treated iSLK cells at 72 hpi.
(PPTX)
Figure S4 Recruitment of EZH2 and RING1B to the
gene regulatory regions of KSHV genes at 72 hpi.
(PPTX)
Figure S5 (A) TIME, SLK or 293T cells were treated with
GSK343 in the absence or presence of KSHV infection and cell
viability was checked by cell counting every 2 days. (B) Naı¨ve
293T cells were pre-treated with GSK343 or DMSO for 48 hours
and then infected with rKSHV.219 for an additional 72 hours.
GFP and RFP expression was analyzed by fluorescent microscopy.
(C) Quantification of RFP positive cells, p,0.0001.
(PPTX)
Figure S6 (A) Infection of SLK and oral epithelial cells OEPI,
SCC15 and NOK with BAC16 KSHV. Photos were taken at
24 hpi. (B) Detection of the expression of the KSHV lytic protein
K3 in KSHV infected OEPI cells at 72 hpi using immunofluo-
rescent analysis.
(PPTX)
Table S1 Primer sequences used in this study.
(DOCX)
Table S2 Pearson correlations in ChIP-on-chip.
(DOCX)
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